| 非活性成分名称 | 给药途径 | 剂型 | CAS登记号 | 物质唯一标识(UNII) | 每单位剂量最大使用量 | 每日最大暴露量(MDE) | 辅料数据 |
|---|---|---|---|---|---|---|---|
| SODIUM ACETATE | INTRALESIONAL | INJECTION | 6131904 | 4550K0SC9B | ADJ PH | 辅料数据 | |
| SODIUM ACETATE | INTRAMUSCULAR | INJECTION | 6131904 | 4550K0SC9B | 19 mg | 辅料数据 | |
| SODIUM ACETATE | INTRAOCULAR | SOLUTION | 6131904 | 4550K0SC9B | 195 mg | 辅料数据 | |
| SODIUM ACETATE | INTRASYNOVIAL | INJECTION | 6131904 | 4550K0SC9B | ADJ PH | 辅料数据 | |
| SODIUM ACETATE | INTRAVENOUS | INJECTION | 6131904 | 4550K0SC9B | 4239 mg | 辅料数据 | |
| SODIUM ACETATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6131904 | 4550K0SC9B | 141 mg | 辅料数据 | |
| SODIUM ACETATE | INTRAVENOUS | INJECTION, SOLUTION | 6131904 | 4550K0SC9B | 328 mg | 辅料数据 | |
| SODIUM ACETATE | INTRAVENOUS | LIQUID | 6131904 | 4550K0SC9B | 0.2 %w/v | 辅料数据 | |
| SODIUM ACETATE | INTRAVENOUS | SOLUTION | 6131904 | 4550K0SC9B | 20 mg | 辅料数据 | |
| SODIUM ACETATE | INTRAVITREAL | INJECTION, SUSPENSION | 6131904 | 4550K0SC9B | 0.39 %w/v | 辅料数据 | |
| SODIUM ACETATE | OPHTHALMIC | EMULSION | 6131904 | 4550K0SC9B | 0.08 %w/v | 辅料数据 | |
| SODIUM ACETATE | OPHTHALMIC | SOLUTION | 6131904 | 4550K0SC9B | 2 mg | 辅料数据 | |
| SODIUM ACETATE | OPHTHALMIC | SOLUTION/ DROPS | 6131904 | 4550K0SC9B | 1.24 %w/v | 辅料数据 | |
| SODIUM ACETATE | ORAL | POWDER, FOR SOLUTION | 6131904 | 4550K0SC9B | 0.1 mg | 辅料数据 | |
| SODIUM ACETATE | ORAL | SOLUTION | 6131904 | 4550K0SC9B | 44 mg | 辅料数据 | |
| SODIUM ACETATE | ORAL | SYRUP | 6131904 | 4550K0SC9B | 43 mg | 辅料数据 | |
| SODIUM ACETATE | PARENTERAL | INJECTION, POWDER, FOR SOLUTION | 6131904 | 4550K0SC9B | 12.5 mg | 辅料数据 | |
| SODIUM ACETATE | PARENTERAL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6131904 | 4550K0SC9B | 250 mg | 辅料数据 | |
| SODIUM ACETATE | SOFT TISSUE | INJECTION | 6131904 | 4550K0SC9B | ADJ PH | 辅料数据 | |
| SODIUM ACETATE | SUBCUTANEOUS | INJECTION | 6131904 | 4550K0SC9B | 19 mg | 辅料数据 |
请输入需要查询的非活性成分(或辅料)的英文名称
可点击列名称排序
药物在线相关数据库
